These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20599818)

  • 41. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium.
    Girard BM; Malley SE; Braas KM; May V; Vizzard MA
    J Mol Neurosci; 2010 Nov; 42(3):378-89. PubMed ID: 20449688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells.
    Ko C; Park-Sarge OK
    Biochem Biophys Res Commun; 2000 Oct; 277(1):270-9. PubMed ID: 11027674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes.
    Gräs S; Hedetoft C; Pedersen SH; Fahrenkrug J
    Biol Reprod; 2000 Jul; 63(1):206-12. PubMed ID: 10859261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium.
    Erdling A; Sheykhzade M; Maddahi A; Bari F; Edvinsson L
    Neuropeptides; 2013 Apr; 47(2):85-92. PubMed ID: 23375386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of VPAC2 receptor and PAC1 receptor splice variants in the trigeminal ganglion of the adult rat.
    Chaudhary P; Baumann TK
    Brain Res Mol Brain Res; 2002 Aug; 104(2):137-42. PubMed ID: 12225867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro.
    Reed HE; Meyer-Spasche A; Cutler DJ; Coen CW; Piggins HD
    Eur J Neurosci; 2001 Feb; 13(4):839-43. PubMed ID: 11207820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.
    Ramos-Álvarez I; Mantey SA; Nakamura T; Nuche-Berenguer B; Moreno P; Moody TW; Maderdrut JL; Coy DH; Jensen RT
    Peptides; 2015 Apr; 66():26-42. PubMed ID: 25698233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PAC1- and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice.
    Hannibal J; Georg B; Fahrenkrug J
    PLoS One; 2017; 12(11):e0188166. PubMed ID: 29155851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of CYP-induced cystitis on PACAP/VIP and receptor expression in micturition pathways and bladder function in mice with overexpression of NGF in urothelium.
    Girard BM; Tompkins JD; Parsons RL; May V; Vizzard MA
    J Mol Neurosci; 2012 Nov; 48(3):730-43. PubMed ID: 22700375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons.
    Tatsuno I; Uchida D; Tanaka T; Saeki N; Hirai A; Saito Y; Moro O; Tajima M
    Brain Res; 2001 Jan; 889(1-2):138-48. PubMed ID: 11166697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. (N-stearyl, norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist.
    Moody TW; Jensen RT; Fridkin M; Gozes I
    J Mol Neurosci; 2002; 18(1-2):29-35. PubMed ID: 11931347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pituitary adenylate cyclase-activating polypeptide].
    Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
    Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytosolic Ca2+ responses to sub-picomolar and nanomolar PACAP in pancreatic beta-cells are mediated by VPAC2 and PAC1 receptors.
    Yamada H; Watanabe M; Yada T
    Regul Pept; 2004 Dec; 123(1-3):147-53. PubMed ID: 15518905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors.
    Cunha-Reis D; Aidil-Carvalho Mde F; Ribeiro JA
    Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development-related splicing regulates pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the retina.
    Lakk M; Szabó B; Völgyi B; Gábriel R; Dénes V
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7825-32. PubMed ID: 23099490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain.
    Hu Z; Lelievre V; Chao A; Zhou X; Waschek JA
    Endocrinology; 2000 Feb; 141(2):657-65. PubMed ID: 10650947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites.
    Kalamatianos T; Kalló I; Piggins HD; Coen CW
    J Comp Neurol; 2004 Jul; 475(1):19-35. PubMed ID: 15176082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.